Conclusions and future directions This study provides a comprehensive evaluation of gastrointestinal adverse events associated with GLP-1 RAs in non-diabetic individuals with overweight or obesity
Rather than jumping to the maximum dose as quickly as the prescribing guidelines allow, consider staying at each dose level for a longer period
Endometriosis is a systemic inflammatory disease, meaning inflammation can affect the entire bodynot just the pelvic region
If approved for both obesity and diabetes indications, Medicare patients with diabetes may get coverage while those with obesity alone are excluded
To view a copy of this license, visit About this article Cite this article Kelly, R.A., Leedale, J., Calleja, D
Built on a collaborative, evidence-based model, Medabolic focuses on reducing health risks